全文获取类型
收费全文 | 3437篇 |
免费 | 336篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 32篇 |
儿科学 | 77篇 |
妇产科学 | 52篇 |
基础医学 | 476篇 |
口腔科学 | 56篇 |
临床医学 | 344篇 |
内科学 | 602篇 |
皮肤病学 | 454篇 |
神经病学 | 255篇 |
特种医学 | 102篇 |
外科学 | 429篇 |
综合类 | 24篇 |
预防医学 | 276篇 |
眼科学 | 39篇 |
药学 | 214篇 |
中国医学 | 5篇 |
肿瘤学 | 343篇 |
出版年
2023年 | 25篇 |
2022年 | 27篇 |
2021年 | 78篇 |
2020年 | 57篇 |
2019年 | 89篇 |
2018年 | 91篇 |
2017年 | 85篇 |
2016年 | 94篇 |
2015年 | 97篇 |
2014年 | 122篇 |
2013年 | 165篇 |
2012年 | 241篇 |
2011年 | 250篇 |
2010年 | 120篇 |
2009年 | 115篇 |
2008年 | 162篇 |
2007年 | 157篇 |
2006年 | 165篇 |
2005年 | 136篇 |
2004年 | 125篇 |
2003年 | 129篇 |
2002年 | 94篇 |
2001年 | 78篇 |
2000年 | 76篇 |
1999年 | 97篇 |
1998年 | 41篇 |
1997年 | 27篇 |
1996年 | 25篇 |
1995年 | 21篇 |
1994年 | 23篇 |
1993年 | 19篇 |
1992年 | 46篇 |
1991年 | 52篇 |
1990年 | 56篇 |
1989年 | 64篇 |
1988年 | 53篇 |
1987年 | 44篇 |
1986年 | 33篇 |
1985年 | 36篇 |
1984年 | 37篇 |
1983年 | 32篇 |
1982年 | 21篇 |
1979年 | 24篇 |
1978年 | 23篇 |
1977年 | 16篇 |
1975年 | 20篇 |
1974年 | 26篇 |
1973年 | 22篇 |
1970年 | 16篇 |
1969年 | 15篇 |
排序方式: 共有3780条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
5.
Hoilund-Carlsen Poul F.; Johansen Allan; Vach Werner; Haghfelt Torben 《European heart journal》2006,27(9):1128-1129
We thank Geluk and Zijlstra for their kind words as well astheir considerations and proposals. The latter hits right intothe heart of the issue: should one stick to the anatomicparadigm urging us to detect and treat coronary stenoses andcalcifications rather than follow 相似文献
6.
The tools available for monitoring necrotic enteritis caused by Clostridium perfringens in broiler chickens have been limited, particularly for identifying subclinical disease. In this study, a modified enzyme-linked immunosorbent assay was used to quantify levels of specific immunoglobulin G to C. perfringens alpha-toxin in serum from broilers. We found significantly higher antibody levels in broilers with a history of subclinical necrotic enteritis compared with a zinc-bacitracin-treated group with a low level of gut lesions. Furthermore, in 4.5-week-old commercial broiler flocks, there was an association between the occurrence of C. perfringens-associated hepatitis at slaughter and the immune response to alpha-toxin. Practical solutions for defining cut-off levels for positive serum samples at individual and flock levels are proposed, and were found to be useful on a set of samples available from flocks with different histories regarding the occurrence of C. perfringens-associated disease. This serological approach seems promising as a diagnostic tool in research and disease monitoring regarding C. perfringens-associated disease. 相似文献
7.
The generation of thrombin-like activity from rat, human, bovine and mouse prothrombin by Echis carinatus venom (ECV) treatment was compared using a partially purified system (i.e. whole ECV and isolated prothrombin). A rapid increase in coagulant activity was obtained within 0.5 to 2 min., being constant upon further incubation for 60 min. A large variation in coagulant activity of the ECV generated thrombin from the four species was found, whereas no differences were found for the amidolytic activities. The coagulant activities of the ECV generated thrombin was also low compared with the corresponding thrombin activities obtained by physiological activation. Coagulant activity of the ECV generated thrombin levelled off at increasing concentration of prothrombin in the sample as measured by the one-stage coagulation assay. By measuring amidolytic activity a linear relationship to the concentration of prothrombin was found, however. These findings indicate that ECV converts prothrombin from the four different species to a thrombin-like protein with properties distinct from -thrombin. The lack of linearity in the ECV generated clot activity with increasing concentration of prothrombin could be explained by assuming a dimerization of the thrombin like protein molecules making them less accessible to fibrinogen. The significance of these observations for the quantification of prothrombin from different species is discussed. 相似文献
8.
K Thomsen B J Riis J S Johansen C Christiansen P R?dbro 《Gynecological endocrinology》1987,1(2):169-175
Bone turnover before and after withdrawal of estrogen/gestagen treatment was studied in a randomized trial with 110 healthy female volunteers, who had passed a natural menopause 6 months to 3 years before the start of the study. Urinary excretion of intravenously injected 99m-technetium diphosphonate was measured as an index of bone turnover; plasma bone Gla protein and serum alkaline phosphatase were measured as indices of bone formation; and fasting urinary excretion of hydroxyproline and calcium were measured as estimates of bone resorption. During 2 years of hormone treatment, all variables decreased highly significantly (p less than 0.001) to a constant low level. Three months after withdrawal all variables increased highly significantly (p less than 0.001) towards, but not above, pretreatment and placebo levels. We conclude that withdrawal of estrogen/gestagen replacement therapy in postmenopausal women increases bone turnover, but not in excess of pretreatment values. This indicates that bone loss (after withdrawal) is similar to that seen in the placebo group and that a rebound phenomenon is unlikely. 相似文献
9.
Tori Smedal Hildegunn Lygren Kjell‐Morten Myhr Rolf Moe‐Nilssen Bente Gjelsvik Olav Gjelsvik Liv Inger Strand 《Physiotherapy research international》2006,11(2):104-116
Background and Purpose . Patients with multiple sclerosis (MS) tend to have movement difficulties, and the effect of physiotherapy for this group of patients has been subjected to limited systematic research. In the present study physiotherapy based on the Bobath concept, applied to MS patients with balance and gait problems, was evaluated. The ability of different functional tests to demonstrate change was evaluated. Method . A single‐subject experimental study design with ABAA phases was used, and two patients with relapsing–remitting MS in stable phase were treated. Tests were performed 12 times, three at each phase: A (at baseline); B (during treatment); A (immediately after treatment); and A (after two months). The key feature of treatment was facilitation of postural activity and selective control of movement. Several performance and self‐report measures and interviews were used. Results . After intervention, improved balance was shown by the Berg Balance Scale (BBS) in both patients, and improved quality of gait was indicated by the Rivermead Visual Gait Assessment (RVGA). The patients also reported improved balance and gait function in the interviews and scored their condition as ‘much improved’. Gait parameters, recorded by an electronic walkway, changed, but differently in the two patients. Among the physical performance tests the BBS and the RVGA demonstrated the highest change, while no or minimal change was demonstrated by the Rivermead Mobility Index (RMI) and Ratings of Perceived Exertion (RPE). Conclusion . The findings indicate that balance and gait can be improved after physiotherapy based on the Bobath concept, but this should be further evaluated in larger controlled trials of patients with MS. Copyright © 2006 John Wiley & Sons, Ltd. 相似文献
10.
J.P. Thyssen P. Jensen B.C. Carlsen K. Engkilde T. Menné J.D. Johansen 《The British journal of dermatology》2009,161(6):1288-1293
Background Chromium allergy has traditionally been caused by occupational skin contact with cement. In 1983, Danish legislation made the addition of ferrous sulphate compulsory in cement to reduce the water‐soluble chromium content to not more than 2 ppm. An effect from this intervention has previously been demonstrated among Danish construction workers. Objectives To investigate the development of chromium allergy among patients with dermatitis tested between 1985 and 2007 in Denmark. Furthermore, to determine causative exposures in patients with chromium allergy. Patients and methods A retrospective analysis of patch test data was performed (n = 16 228) and charts from patients with chromium allergy were reviewed. Comparisons were made using a χ2 test. Logistic regression analyses were used to test for associations. Results The prevalence of chromium allergy decreased significantly from 3·6% in 1985 to 1% in 1995 (Ptrend < 0·001) but increased to 3·3% in 2007 (Ptrend < 0·001). The frequency of clinically relevant cement exposure decreased significantly among patients with chromium allergy from 12·7% in 1989–1994 to 3·0% (P < 0·01) in 1995–2007, whereas the frequency of relevant leather exposure increased significantly from 24·1% during 1989–1994 to 45·5% during 1995–2007 (P < 0·02). Conclusions Chromium allergy is currently increasing in Denmark due to leather exposure. 相似文献